{"id":3212,"date":"2025-01-10T16:07:44","date_gmt":"2025-01-10T08:07:44","guid":{"rendered":"\/\/www.axcessimc.com\/?p=3212"},"modified":"2025-01-14T16:07:56","modified_gmt":"2025-01-14T08:07:56","slug":"%e5%90%9b%e5%ae%9e%e7%94%9f%e7%89%a9%e5%ae%a3%e5%b8%83%e6%b0%91%e5%be%97%e7%bb%b4%e6%b2%bb%e7%96%97%e6%96%b0%e5%86%a0%e8%8e%b7%e5%b8%b8%e8%a7%84%e6%89%b9%e5%87%86","status":"publish","type":"post","link":"\/\/www.axcessimc.com\/%e5%90%9b%e5%ae%9e%e7%94%9f%e7%89%a9%e5%ae%a3%e5%b8%83%e6%b0%91%e5%be%97%e7%bb%b4%e6%b2%bb%e7%96%97%e6%96%b0%e5%86%a0%e8%8e%b7%e5%b8%b8%e8%a7%84%e6%89%b9%e5%87%86\/","title":{"rendered":"\u541b\u5b9e\u751f\u7269\u5ba3\u5e03\u6c11\u5f97\u7ef4\u00ae\u6cbb\u7597\u65b0\u51a0\u83b7\u5e38\u89c4\u6279\u51c6"},"content":{"rendered":"\n
\u5317\u4eac\u65f6\u95f42025\u5e741\u670810\u65e5\uff0c\u541b\u5b9e\u751f\u7269\uff081877.HK\uff0c688180.SH\uff09\u5ba3\u5e03\uff0c\u516c\u53f8\u65d7\u4e0b\u7684\u53e3\u670d\u6838\u82f7\u7c7b\u6297\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\uff08SARS-CoV-2\uff09\u836f\u7269\u6c11\u5f97\u7ef4\u00ae<\/sup>\uff08\u6c22\u6eb4\u9178\u6c18\u745e\u7c73\u5fb7\u97e6\u7247\uff0c\u4ea7\u54c1\u4ee3\u53f7\uff1aVV116\/JT001\uff09\u7528\u4e8e\u6cbb\u7597\u8f7b\u4e2d\u5ea6\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\uff08COVID-19\uff09\u7684\u6210\u5e74\u60a3\u8005\u7684\u9002\u5e94\u75c7\u6b63\u5f0f\u83b7\u5f97\u56fd\u5bb6\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08NMPA\uff09\u540c\u610f\uff0c\u7531\u9644\u6761\u4ef6\u6279\u51c6\u8f6c\u4e3a\u5e38\u89c4\u6279\u51c6\u3002<\/p>\n\n\n\n 2023\u5e741\u670828\u65e5\uff0c\u57fa\u4e8e\u4e00\u9879\u5728\u4f34\u6216\u4e0d\u4f34\u6709\u8fdb\u5c55\u4e3a\u91cd\u75c7\u9ad8\u98ce\u9669\u56e0\u7d20\u7684\u8f7b\u4e2d\u5ea6COVID-19\u60a3\u8005\u4e2d\u5f00\u5c55\u7684\u591a\u4e2d\u5fc3\u3001\u53cc\u76f2\u3001\u968f\u673a\u3001\u5b89\u6170\u5242\u5bf9\u7167\u3001\u2162\u671f\u4e34\u5e8a\u7814\u7a76\uff08JT001-015\u7814\u7a76\uff0cNCT05582629\uff09\uff0c\u6c11\u5f97\u7ef4\u00ae<\/sup>\u83b7\u5f97\u56fd\u5bb6\u836f\u76d1\u5c40\u9644\u6761\u4ef6\u4e0a\u5e02\u6279\u51c6\u3002<\/p>\n\n\n\n \u6b64\u6b21\u6c11\u5f97\u7ef4\u00ae<\/sup>\u5e38\u89c4\u6279\u51c6\u57fa\u4e8e\u591a\u9879\u4e34\u5e8a\u53ca\u975e\u4e34\u5e8a\u7814\u7a76\uff0c\u5305\u62ecJT001-015\u7814\u7a76\u548c\u4e00\u9879\u7eb3\u5165\u8fd18000\u4f8b\u60a3\u8005\u7684\u771f\u5b9e\u4e16\u754c\u7814\u7a76\u3002\u7814\u7a76\u7ed3\u679c\u663e\u793a\uff0c\u5728\u8f7b\u3001\u4e2d\u5ea6\u65b0\u51a0\u60a3\u8005\u4e2d\uff0c\u6c11\u5f97\u7ef4\u00ae<\/sup>\u53ef\u663e\u8457\u52a0\u901f\u75c7\u72b6\u7f13\u89e3\u548c\u6d88\u5931\u3001\u7f29\u77ed\u75c5\u7a0b\uff0c\u52a0\u5feb\u75c5\u6bd2\u8f6c\u9634\uff0c\u964d\u4f4e\u91cd\u75c7COVID-19\u6216\u5168\u56e0\u6b7b\u4ea1\u53d1\u751f\u7387\uff0c\u5bf9\u8001\u5e74\u548c\u9ad8\u98ce\u9669\u60a3\u8005\u6548\u679c\u66f4\u663e\u8457\u3002\u5728\u8f7b\u4e2d\u5ea6\u809d\u80be\u529f\u80fd\u4e0d\u5168\u7684\u60a3\u8005\u4e2d\uff0c\u6c11\u5f97\u7ef4\u00ae<\/sup>\u8868\u73b0\u51fa\u826f\u597d\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\uff0c\u60a3\u8005\u5728\u670d\u836f\u8fc7\u7a0b\u4e2d\u65e0\u9700\u6216\u4ec5\u9700\u5c11\u91cf\u8c03\u6574\u7528\u836f\u5242\u91cf\u3002\u540c\u65f6\uff0c\u836f\u7406\u7814\u7a76\u663e\u793a\u6c11\u5f97\u7ef4\u00ae<\/sup>\u57fa\u672c\u65e0\u836f\u7269\u95f4\u76f8\u4e92\u4f5c\u7528\uff0c\u5927\u5927\u51cf\u5c11\u4e86\u7528\u836f\u7981\u5fcc\uff0c\u6709\u6548\u4fdd\u969c\u60a3\u8005\u7684\u5408\u5e76\u7528\u836f\uff0c\u4e3a\u7279\u6b8a\u4eba\u7fa4\u63d0\u4f9b\u4e86\u66f4\u5b89\u5168\u3001\u66f4\u6709\u6548\u7684\u9009\u62e9\u3002<\/p>\n\n\n\n \u6b64\u5916\uff0c\u76f8\u5173\u7814\u7a76\u8868\u660e\uff0c\u6c11\u5f97\u7ef4\u00ae<\/sup>\u53ef\u663e\u8457\u6291\u5236\u65b0\u51a0\u75c5\u6bd2XBB.1.16\u3001EG.5\u3001JN.1\u53d8\u5f02\u682a\uff0c\u5bf9\u4e3b\u8981\u6d41\u884c\u682a\u6301\u7eed\u6709\u6548\u3002<\/p>\n\n\n\n \u6c11\u5f97\u7ef4\u00ae<\/sup>\u4e0a\u5e02\u4ee5\u6765\uff0c\u53ef\u53ca\u6027\u4e0d\u65ad\u63d0\u5347\uff0c\u81ea2024\u5e741\u67081\u65e5\u8d77\u88ab\u6b63\u5f0f\u7eb3\u5165\u56fd\u5bb6\u533b\u4fdd\u836f\u54c1\u76ee\u5f55\uff0c\u6bcf\u4e2a\u7597\u7a0b\u4ef7\u683c\u4e3a475\u5143\uff0c\u6309\u7167\u4e59\u7c7b\u533b\u4fdd\u62a5\u9500\uff0c\u5927\u5e45\u4f4e\u4e8e\u540c\u7c7b\u8fdb\u53e3\u4ea7\u54c1\u3002\u60a3\u8005\u53ef\u5728\u533b\u9662\u53ca\u4e92\u8054\u7f51\u533b\u9662\u5c31\u8bca\u8d2d\u4e70\uff0c\u663e\u8457\u63d0\u5347\u4e86\u6297\u75c5\u6bd2\u836f\u7269\u7684\u53ef\u53ca\u6027\u548c\u4fbf\u5229\u6027\u3002<\/p>\n\n\n\n <\/p>\n\n\n\n <\/p>\n\n\n\n \u5173\u4e8e\u6c22\u6eb4\u9178\u6c18\u745e\u7c73\u5fb7\u97e6\u7247\uff08\u6c11\u5f97\u7ef4\u00ae<\/sup>\uff0cVV116\/JT001\uff09<\/strong><\/p>\n\n\n\n \u6c11\u5f97\u7ef4\u00ae<\/sup>\u662f\u4e00\u6b3e\u53e3\u670d\u6838\u82f7\u7c7b\u836f\u7269\uff0c\u53ef\u6291\u5236SARS-CoV-2\u590d\u5236\u3002\u4e34\u5e8a\u524d\u7814\u7a76\u663e\u793a\uff0c\u6c11\u5f97\u7ef4\u00ae<\/sup>\u5bf9\u5305\u62ec\u5965\u5bc6\u514b\u620e\u5728\u5185\u7684\u65b0\u51a0\u75c5\u6bd2\u539f\u59cb\u682a\u548c\u7a81\u53d8\u682a\u8868\u73b0\u51fa\u663e\u8457\u7684\u6297\u75c5\u6bd2\u4f5c\u7528\uff0c\u4e14\u65e0\u9057\u4f20\u6bd2\u6027\u3002\u8be5\u4ea7\u54c1\u7531\u4e2d\u56fd\u79d1\u5b66\u9662\u4e0a\u6d77\u836f\u7269\u7814\u7a76\u6240\u3001\u4e2d\u56fd\u79d1\u5b66\u9662\u6b66\u6c49\u75c5\u6bd2\u7814\u7a76\u6240\u3001\u4e2d\u56fd\u79d1\u5b66\u9662\u65b0\u7586\u7406\u5316\u6280\u672f\u7814\u7a76\u6240\u3001\u4e2d\u56fd\u79d1\u5b66\u9662\u4e2d\u4e9a\u836f\u7269\u7814\u53d1\u4e2d\u5fc3\/\u4e2d\u4e4c\u533b\u836f\u79d1\u6280\u57ce\uff08\u79d1\u6280\u90e8\u201c\u4e00\u5e26\u4e00\u8def\u201d\u8054\u5408\u5b9e\u9a8c\u5ba4\uff09\u3001\u4e34\u6e2f\u5b9e\u9a8c\u5ba4\u3001\u82cf\u5dde\u65fa\u5c71\u65fa\u6c34\u751f\u7269\u533b\u836f\u6709\u9650\u516c\u53f8\u548c\u541b\u5b9e\u751f\u7269\u5171\u540c\u7814\u53d1\u3002<\/p>\n\n\n\n \u5728\u65b0\u51a0\u75ab\u60c5\u671f\u95f4\uff0c\u6c11\u5f97\u7ef4\u00ae<\/sup>\u5728\u56fd\u5185\u5916\u5f00\u5c55\u4e86\u591a\u9879\u4e34\u5e8a\u7814\u7a76\u3002\u4e00\u9879\u5728\u4f34\u6709\u8fdb\u5c55\u4e3a\u91cd\u75c7\u9ad8\u98ce\u9669\u56e0\u7d20\u7684\u8f7b\u4e2d\u5ea6COVID-19\u60a3\u8005\u4e2d\u5bf9\u6bd4PAXLOVID\u7528\u4e8e\u8f7b\u4e2d\u5ea6COVID-19\u65e9\u671f\u6cbb\u7597\u7684\u2162\u671f\u4e34\u5e8a\u7814\u7a76\uff08JT001-010\uff09\u83b7\u5f97\u56fd\u9645\u6743\u5a01\u671f\u520a\u300a\u65b0\u82f1\u683c\u5170\u533b\u5b66\u6742\u5fd7\u300b\uff08The New England Journal of Medicine<\/em>\uff0cIF\uff1a96.2\uff09\u53d1\u8868[1]<\/sup>\uff0c\u53e6\u4e00\u9879\u5728\u4f34\u6216\u4e0d\u4f34\u6709\u8fdb\u5c55\u4e3a\u91cd\u75c7\u9ad8\u98ce\u9669\u56e0\u7d20\u7684\u8f7b\u4e2d\u5ea6COVID-19\u60a3\u8005\u4e2d\u5f00\u5c55\u7684\u2162\u671f\u4e34\u5e8a\u7814\u7a76\uff08JT001-015\uff09\u83b7\u5f97\u56fd\u9645\u9876\u5c16\u611f\u67d3\u75c5\u5b66\u671f\u520a\u300a\u67f3\u53f6\u5200-\u611f\u67d3\u75c5\u5b66\u300b\uff08The Lancet Infectious Diseases<\/em>\uff0cIF\uff1a36.4\uff09\u53d1\u8868[2]<\/sup>\u3002<\/p>\n\n\n\n 2021\u5e7412\u6708\uff0c\u6c11\u5f97\u7ef4\u00ae<\/sup>\u5728\u4e4c\u5179\u522b\u514b\u65af\u5766\u83b7\u5f97\u6279\u51c6\u7528\u4e8e\u6cbb\u7597\u4e2d\/\u91cd\u5ea6COVID-19\u60a3\u8005\u3002<\/p>\n\n\n\n 2023\u5e741\u6708\uff0c\u6c11\u5f97\u7ef4\u00ae<\/sup>\u5728\u4e2d\u56fd\u83b7\u5f97\u6279\u51c6\u7528\u4e8e\u6cbb\u7597\u8f7b\u4e2d\u5ea6COVID-19\u7684\u6210\u5e74\u60a3\u8005\uff0c\u5e76\u4e8e2023\u5e741\u6708\u8d77\u4e34\u65f6\u6027\u7eb3\u5165\u533b\u4fdd\u652f\u4ed8\u8303\u56f4\uff0c2024\u5e741\u6708\u8d77\u7eb3\u5165\u6b63\u5f0f\u56fd\u5bb6\u533b\u4fdd\u76ee\u5f55\u3002<\/p>\n\n\n\n \u7528\u4e8e\u6cbb\u7597\u8f7b\u4e2d\u5ea6\u65b0\u578b\u51a0\u72b6\u75c5\u6bd2\u611f\u67d3\uff08COVID-19\uff09\u7684\u6210\u5e74\u60a3\u8005<\/p>\n","protected":false},"author":4,"featured_media":3216,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3212","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1"],"yoast_head":"\n1. <\/em>\u672c\u6750\u6599\u65e8\u5728\u4f20\u9012\u524d\u6cbf\u4fe1\u606f\uff0c\u65e0\u610f\u5411\u60a8\u505a\u4efb\u4f55\u4ea7\u54c1\u7684\u63a8\u5e7f\uff0c\u4e0d\u4f5c\u4e3a\u4e34\u5e8a\u7528\u836f\u6307\u5bfc\u3002<\/em><\/h6>\n\n\n\n
2. <\/em>\u82e5\u60a8\u60f3\u4e86\u89e3\u5177\u4f53\u75be\u75c5\u8bca\u7597\u4fe1\u606f\uff0c\u8bf7\u9075\u4ece\u533b\u7597\u536b\u751f\u4e13\u4e1a\u4eba\u58eb\u7684\u610f\u89c1\u4e0e\u6307\u5bfc\u3002<\/em><\/h6>\n\n\n\n
\u3010\u53c2\u8003\u6587\u732e\u3011<\/h5>\n\n\n\n
[1] Cao Z, Gao W, Bao H, et al. VV116 versus Nirmatrelvir\u2013Ritonavir for Oral Treatment of Covid-19. N Engl J Med. DOI: 10.1056\/NEJMoa2208822.<\/h5>\n\n\n\n
[2] Xiaohong Fan, Xiahong Dai, Yun Ling, et al. Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled study. The Lancet Infectious Diseases. DOI:10.1016\/S1473-3099(23)00577-7.<\/h5>\n","protected":false},"excerpt":{"rendered":"